Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Auteurs » - entrée « Michael Schulzer »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Michael Schocke < Michael Schulzer < Michael Schüpbach  Facettes :

List of bibliographic references indexed by Michael Schulzer

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000401 (2011) Raúl De La Fuente-Fernández [Canada] ; Michael Schulzer [Canada] ; Lisa Kuramoto [Canada] ; Jacquelyn Cragg [Canada] ; Nandhagopal Ramachandiran [Canada] ; Wing L. Au [Canada] ; Edwin Mak [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Age‐specific progression of nigrostriatal dysfunction in Parkinson's disease
000559 (2010) R. Nandhagopal ; Andre R. Troiano ; Edwin Mak ; Michael Schulzer ; Mary Catherine Bushnell [Canada] ; Alexander Jon StoesslResponse to Heat Pain Stimulation in Idiopathic Parkinson's Disease
000742 (2010) Vesna Sossi [Canada] ; Raul De La Fuente-Fernández [Canada] ; Ramachandiran Nandhagopal [Canada] ; Michael Schulzer [Canada] ; Jessamyn Mckenzie [Canada] ; Thomas J. Ruth [Canada] ; Jan O. Aasly [Norvège] ; Matthew J. Farrer [États-Unis] ; Zbigniew K. Wszolek [États-Unis] ; Jon A. Stoessl [Canada]Dopamine turnover increases in asymptomatic LRRK2 mutations carriers
000E19 (2008) W. R. Wayne Martin ; Marguerite Wieler ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada]Dihydrotetrabenazine positron emission tomography imaging in early, untreated Parkinson's disease
001069 (2007) Vesna Sossi [Canada] ; Raúl De La Fuente-Fernández [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada]Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study
001301 (2006) Rodrigo Mercado [Canada] ; Constantine Constantoyannis [Canada] ; Tomasz Mandat [Canada] ; Ajit Kumar [Canada] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] ; Christopher R. Honey [Canada]Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation
001365 (2006) Vesna Sossi ; Rau L De La Fuente-Ferna Ndez [Espagne] ; Michael Schulzer ; John Adams [Canada] ; Jon StoesslAge-related differences in levodopa dynamics in Parkinson's: implications for motor complications
001679 (2003) Ajit Kumar ; Sharanpal Mann ; Vesna Sossi ; Thomas J. Ruth ; A. Jon Stoessl ; Michael Schulzer ; Chong S. Lee[11C]DTBZ‐PET correlates of levodopa responses in asymmetric Parkinson’s disease
001B06 (2001) Raúl De La Fuente-Fernández [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnover
001D58 (1999) Claudia Schwab [Canada] ; Michael Schulzer [Canada] ; John C. Steele ; Patrick L. Mcgeer [Canada]On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam
001F75 (1997) Francois J. G. Vingerhoets [Canada] ; Michael Schulzer [Canada] ; Donald B. Calne [Canada] ; Snow [Canada]Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion?

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Parkinson's disease
118F-DA = 18F-fluorodopamine
13OMFD = 3-O-methylfluorodopa
1Abbreviations: BP = binding potential; DA = dopamine; [11C]DTBZ = [11C](±)dihydrotetrabenazine; Emax = magnitude of levodopa response; EC50 = levodopa concentration producing 50% of the maximal response; ROI = region of interest; T1/2eq = equilibration half‐life
1Alzheimer’s disease
1DA = dopamine
1DA turnover
1EDV = effective DA distribution volume
1FD = 18F-fluorodopa
1Heat Pain
1Immunocytochemistry
1Keywords: Parkinson’s disease; PET; motor fluctuations; levodopa; dihydrotetrabenazine
1Ki = FD uptake rate constant
1LRRK2 mutation
1Medication Status
1Neurofibrillary tangles
1Neuronal death
1PET = positron emission tomography
1PET imaging
1Parkinson dementia complex of Guam
1Parkinson's Disease
1ROIs = regions of interest
1Survival time
1Unpleasantness
1age dependence
1deep brain stimulation
1dopamine turnover
1dopaminergic system
1motor complications
1nocebo
1placebo
1subthalamic nucleus

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Michael Schulzer" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Michael Schulzer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Michael Schulzer
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024